Abstract
The last decade has seen rapid discoveries in the genetic basis of disease associated with the Human Genome Project (HGP). Understanding the social (including legal, ethical and political) impact of these findings, however, lags far behind. This paper addresses the social context of biotechnologies arising out of this project as well as the tension between the individual and collective uses of these technologies. The danger is that, in the context of a global trend towards conservatism, the ideology of genetic reductionism is legitimizing the abandonment of collectivist responses to social problems in favour of the promotion of individualist ones. In seeking to pursue health policy objectives of reducing premature morbidity and mortality more traditional public health concerns are in danger of being marginalized.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
